|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007113,
umls-concept:C0030705,
umls-concept:C0123931,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C0443252,
umls-concept:C0445204,
umls-concept:C0671970,
umls-concept:C1274040,
umls-concept:C1514888,
umls-concept:C1517927,
umls-concept:C1559154
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2011-2-28
|
|
pubmed:abstractText |
Preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer has shown benefit over postoperative CRT; however, a standard CRT regimen has yet to be defined. We performed a prospective concurrent CRT Phase II study with irinotecan and capecitabine in patients with locally advanced rectal cancer to investigate the efficacy and safety of this regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
pubmed-author:ChangHee JinHJ,
pubmed-author:ChoiHyo SeongHS,
pubmed-author:HongYong SangYS,
pubmed-author:JeongJun YongJY,
pubmed-author:JeongSeung-YongSY,
pubmed-author:JungKyung HaeKH,
pubmed-author:KimDae YongDY,
pubmed-author:KimDae-HyunDH,
pubmed-author:LimSeok-ByungSB,
pubmed-author:ParkJae-GahbJG,
pubmed-author:SohnDae KyungDK
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
79
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1171-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20605355-Adult,
pubmed-meshheading:20605355-Aged,
pubmed-meshheading:20605355-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20605355-Camptothecin,
pubmed-meshheading:20605355-Combined Modality Therapy,
pubmed-meshheading:20605355-Confidence Intervals,
pubmed-meshheading:20605355-Deoxycytidine,
pubmed-meshheading:20605355-Disease-Free Survival,
pubmed-meshheading:20605355-Drug Administration Schedule,
pubmed-meshheading:20605355-Female,
pubmed-meshheading:20605355-Fluorouracil,
pubmed-meshheading:20605355-Humans,
pubmed-meshheading:20605355-Male,
pubmed-meshheading:20605355-Middle Aged,
pubmed-meshheading:20605355-Preoperative Period,
pubmed-meshheading:20605355-Rectal Neoplasms,
pubmed-meshheading:20605355-Remission Induction,
pubmed-meshheading:20605355-Survival Rate
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resectable rectal cancer: long-term results of a Phase II study.
|
|
pubmed:affiliation |
Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
